{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:34:06Z","timestamp":1792805646352,"version":"4.5.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Department of Biotechnology, New Delhi","award":["BT\/PR10272\/BRB\/10\/1266\/2013"],"award-info":[{"award-number":["BT\/PR10272\/BRB\/10\/1266\/2013"]}]},{"name":"Department of Science and Technology, New Delhi","award":["SR\/FST\/LS11-036\/2014(C)"],"award-info":[{"award-number":["SR\/FST\/LS11-036\/2014(C)"]}]},{"name":"University Grants Commission, New Delhi","award":["F.4.13\/2018\/DRS-III (SAP-II)"],"award-info":[{"award-number":["F.4.13\/2018\/DRS-III (SAP-II)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11010-021-04088-3","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T23:02:45Z","timestamp":1613084565000},"page":"2269-2282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Role of TSC1 in physiology and diseases"],"prefix":"10.1007","volume":"476","author":[{"given":"Karthik","family":"Mallela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0537-6560","authenticated-orcid":false,"given":"Arun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"4088_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M van Slegtenhorst","year":"1997","unstructured":"van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JB, Ward S, Green AJ, Yates JR, Kwiatkowska J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ (1997) Identification of the tuberous sclerosis gene on chromosome 9q34. Science 277:805\u2013808","journal-title":"Science"},{"key":"4088_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0378-1119(03)00821-7","volume":"320","author":"M Ali","year":"2003","unstructured":"Ali M, Girimaji SC, Kumar A (2003) Identification of a core promoter and a novel isoform of the human TSC1 gene transcript and structural comparison with mouse homolog. Gene 320:145\u2013154","journal-title":"Gene"},{"key":"4088_CR3","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2174\/138920208786241243","volume":"9","author":"V Napolioni","year":"2008","unstructured":"Napolioni V, Curatolo P (2008) Genetics and molecular biology of tuberous sclerosis complex. Curr Genom 9:475\u2013487","journal-title":"Curr Genom"},{"key":"4088_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.molmed.2007.06.003","volume":"13","author":"PJ De Vries","year":"2007","unstructured":"De Vries PJ, Howe CJ (2007) The tuberous sclerosis complex proteins- a GRIPP on cognition and neurodevelopment. Trends Mol Med 13:319\u2013326","journal-title":"Trends Mol Med"},{"key":"4088_CR5","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1093\/hmg\/ddn098","volume":"17","author":"LS Pymar","year":"2008","unstructured":"Pymar LS, Platt FM, Askham JM, Morrison EE, Knowles MA (2008) Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms. Hum Mol Genet 17:2006\u20132017","journal-title":"Hum Mol Genet"},{"key":"4088_CR6","doi-asserted-by":"publisher","first-page":"e93940","DOI":"10.1371\/journal.pone.0093940","volume":"9","author":"AJ Santiago Lima","year":"2014","unstructured":"Santiago Lima AJ, Hoogeveen-Westerveld M, Nakashima A, Maat-Kievit A, van den Ouweland A, Halley D, Kikkawa U, Nellist M (2014) Identification of regions critical for the integrity of the TSC1-TSC2-TBC1D7 complex. PLoS ONE 9:e93940","journal-title":"PLoS ONE"},{"key":"4088_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD (2008) The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 412:179\u2013190","journal-title":"Biochem J"},{"key":"4088_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","volume":"47","author":"CC Dibble","year":"2012","unstructured":"Dibble CC, Elis W, Menon S, Qin W, Klekota J, Asara JM, Finan PM, Kwiatkowski DJ, Murphy LO, Manning BD (2012) TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell 47:535\u2013546","journal-title":"Mol Cell"},{"key":"4088_CR9","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0002-9440(10)62958-6","volume":"167","author":"BC Mak","year":"2005","unstructured":"Mak BC, Kenerson HL, Aicher LD, Barnes EA, Yeung RS (2005) Aberrant beta-catenin signaling in tuberous sclerosis. Am J Pathol 167:107\u2013116","journal-title":"Am J Pathol"},{"key":"4088_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/ddp483","volume":"19","author":"D Adhikari","year":"2010","unstructured":"Adhikari D, Zheng W, Shen Y, Gorre N, Hamalainen T, Cooney AJ, Huhtaniemi I, Lan ZJ, Liu K (2010) Tsc\/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles. Hum Mol Genet 19:397\u2013410","journal-title":"Hum Mol Genet"},{"key":"4088_CR11","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/hmg\/ddq570","volume":"20","author":"AJ Malhowski","year":"2011","unstructured":"Malhowski AJ, Hira H, Bashiruddin S, Warburton R, Goto J, Robert B, Kwiatkowski DJ, Finlay GA (2011) Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin. Hum Mol Genet 20:1290\u20131305","journal-title":"Hum Mol Genet"},{"key":"4088_CR12","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/s41401-019-0244-6","volume":"40","author":"Q Lu","year":"2019","unstructured":"Lu Q, Chen YB, Yang H, Wang WW, Li CC, Wang L, Wang J, Du L, Yin XX (2019) Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy. Acta Pharmacol Sin 40:1555\u20131567","journal-title":"Acta Pharmacol Sin"},{"key":"4088_CR13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1146\/annurev-cellbio-111315-125341","volume":"32","author":"EK Paluch","year":"2016","unstructured":"Paluch EK, Aspalter IM, Sixt M (2016) Focal adhesion-independent cell migration. Annu Rev Cell Dev Biol 32:469\u2013490","journal-title":"Annu Rev Cell Dev Biol"},{"key":"4088_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fcell.2019.00107","volume":"7","author":"J Pijuan","year":"2019","unstructured":"Pijuan J, Barcelo C, Moreno DF, Maiques O, Siso P, Marti RM, Macia A, Panosa A (2019) In vitro cell migration, invasion and adhesion assays: from cell imaging to data analysis. Front Cell Dev Biol 7:107","journal-title":"Front Cell Dev Biol"},{"key":"4088_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/35010550","volume":"2","author":"RF Lamb","year":"2000","unstructured":"Lamb RF, Roy C, Diefenbach TJ, Vinters HV, Johnson MW, Jay DG, Hall A (2000) The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat Cell Biol 2:281\u2013287","journal-title":"Nat Cell Biol"},{"key":"4088_CR16","doi-asserted-by":"publisher","first-page":"e54503","DOI":"10.1371\/journal.pone.0054503","volume":"8","author":"M Ohsawa","year":"2013","unstructured":"Ohsawa M, Kobayashi T, Okura H, Igarashi T, Mizuguchi M, Hino O (2013) TSC1 controls distribution of actin fibers through its effect on function of Rho family of small GTPases and regulates cell migration and polarity. PLoS ONE 8:e54503","journal-title":"PLoS ONE"},{"key":"4088_CR17","doi-asserted-by":"publisher","first-page":"44180","DOI":"10.1074\/jbc.M207211200","volume":"277","author":"LA Haddad","year":"2002","unstructured":"Haddad LA, Smith N, Bowser M, Niida Y, Murthy V, Gonzalez-Agosti C, Ramesh V (2002) The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton. J Biol Chem 277:44180\u201344186","journal-title":"J Biol Chem"},{"key":"4088_CR18","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1101\/gad.16750211","volume":"25","author":"Z Zhou","year":"2011","unstructured":"Zhou Z, Shrikhande G, Xu J, McKay RM, Burns DK, Johnson JE, Parada LF (2011) Tsc1 mutant neural stem\/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle. Genes Dev 25:1595\u20131600","journal-title":"Genes Dev"},{"key":"4088_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5487\/TR.2010.26.4.245","volume":"26","author":"H Son","year":"2010","unstructured":"Son H, Moon A (2010) Epithelial-mesenchymal transition and cell invasion. Toxicol Res 26:245\u2013252","journal-title":"Toxicol Res"},{"key":"4088_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.devcel.2015.01.026","volume":"32","author":"A Thien","year":"2015","unstructured":"Thien A, Prentzell MT, Holzwarth B, Klasener K, Kuper I, Boehlke C, Sonntag AG, Ruf S, Maerz L, Nitschke R, Grellscheid SN, Reth M, Walz G, Baumeister R, Neumann-Haefelin E, Thedieck K (2015) TSC1 activates TGF-\u03b2-Smad2\/3 signaling in growth arrest and epithelial-to-mesenchymal transition. Dev Cell 32:617\u2013630","journal-title":"Dev Cell"},{"key":"4088_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1146\/annurev-cancerbio-040716-075628","volume":"1","author":"CJ Sherr","year":"2017","unstructured":"Sherr CJ, Bartek J (2017) Cell cycle-targeted cancer therapies. Annu Rev Cancer Biol 1:41\u201357","journal-title":"Annu Rev Cancer Biol"},{"key":"4088_CR22","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1093\/hmg\/9.12.1721","volume":"9","author":"A Miloloza","year":"2000","unstructured":"Miloloza A, Rosner M, Nellist M, Halley D, Bernaschek G, Hengstschlager M (2000) The TSC1 gene product hamartin negatively regulates cell proliferation. Hum Mol Genet 9:1721\u20131727","journal-title":"Hum Mol Genet"},{"key":"4088_CR23","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","volume":"19","author":"G Benvenuto","year":"2000","unstructured":"Benvenuto G, Li S, Brown SJ, Braverman R, Vass WC, Cheadle JP, Halley DJ, Sampson JR, Wienecke R, DeClue JE (2000) The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene 19:6306","journal-title":"Oncogene"},{"key":"4088_CR24","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1093\/nar\/gku278","volume":"42","author":"SA Pradhan","year":"2014","unstructured":"Pradhan SA, Rather MI, Tiwari A, Bhat VK, Kumar A (2014) Evidence that TSC2 acts as a transcription factor and binds to and represses the promoter of epiregulin. Nucleic Acids Res 42:6243\u20136255","journal-title":"Nucleic Acids Res"},{"key":"4088_CR25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/jnen\/61.2.154","volume":"61","author":"A Miloloza","year":"2002","unstructured":"Miloloza A, Kubista M, Rosner M, Hengstschlager M (2002) Evidence for separable functions of tuberous sclerosis gene products in mammalian cell cycle regulation. J Neuropathol Exp Neurol 61:154\u2013163","journal-title":"J Neuropathol Exp Neurol"},{"key":"4088_CR26","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1101\/gad.901101","volume":"15","author":"X Gao","year":"2001","unstructured":"Gao X, Pan D (2001) TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth. Genes Dev 15:1383\u20131392","journal-title":"Genes Dev"},{"key":"4088_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0092-8674(01)00333-6","volume":"105","author":"CJ Potter","year":"2001","unstructured":"Potter CJ, Huang H, Xu T (2001) Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth cell proliferation and organ size. Cell 105:357\u2013368","journal-title":"Cell"},{"key":"4088_CR28","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0092-8674(01)00332-4","volume":"105","author":"N Tapon","year":"2001","unstructured":"Tapon N, Ito N, Dickson BJ, Treisman JE, Hariharan IK (2001) The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell 105:345\u2013355","journal-title":"Cell"},{"key":"4088_CR29","doi-asserted-by":"publisher","first-page":"51372","DOI":"10.1074\/jbc.M303956200","volume":"278","author":"A Astrinidis","year":"2003","unstructured":"Astrinidis A, Senapedis W, Coleman TR, Henske EP (2003) Cell cycle-regulated phosphorylation of hamartin, the product of the tuberous sclerosis complex 1 gene by cyclin-dependent kinase 1\/cyclin B. J Biol Chem 278:51372\u201351379","journal-title":"J Biol Chem"},{"key":"4088_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/hmg\/ddi444","volume":"15","author":"A Astrinidis","year":"2006","unstructured":"Astrinidis A, Senapedis W, Henske EP (2006) Hamartin, the tuberous sclerosis complex 1 gene product, interacts with polo-like kinase 1 in a phosphorylation-dependent manner. Hum Mol Genet 15:287\u2013297","journal-title":"Hum Mol Genet"},{"key":"4088_CR31","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1158\/0008-5472.CAN-17-3046","volume":"78","author":"Z Li","year":"2018","unstructured":"Li Z, Kong Y, Song L, Luo Q, Liu J, Shao C, Hou X, Liu X (2018) Plk1-mediated phosphorylation of TSC1 enhances the efficacy of rapamycin. Cancer Res 78:2864\u20132875","journal-title":"Cancer Res"},{"key":"4088_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3390\/genes10030208","volume":"10","author":"G de Carcer","year":"2019","unstructured":"de Carcer G (2019) The mitotic cancer target Polo-like kinase 1: oncogene or tumor suppressor? Genes 10:208","journal-title":"Genes"},{"key":"4088_CR33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.2174\/1389450116666150223162737","volume":"18","author":"SA Gradilone","year":"2017","unstructured":"Gradilone SA, Pisarello MJL, LaRusso NF (2017) Primary cilia in tumor biology: the primary cilium as a therapeutic target in cholangiocarcinoma. Curr Drug Targets 18:958\u2013963","journal-title":"Curr Drug Targets"},{"key":"4088_CR34","first-page":"3041","volume":"17","author":"M Higgins","year":"2019","unstructured":"Higgins M, Obaidi I, McMorrow T (2019) Primary cilia and their role in cancer. Oncol Lett 17:3041\u20133047","journal-title":"Oncol Lett"},{"key":"4088_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13630-016-0027-3","volume":"5","author":"M Cao","year":"2016","unstructured":"Cao M, Zhong Q (2016) Cilia in autophagy and cancer. Cilia 5:4","journal-title":"Cilia"},{"key":"4088_CR36","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/hmg\/ddn325","volume":"18","author":"TR Hartman","year":"2008","unstructured":"Hartman TR, Liu D, Zilfou JT, Robb V, Morrison T, Watnick T, Henske EP (2008) The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway. Hum Mol Genet 18:151\u2013163","journal-title":"Hum Mol Genet"},{"key":"4088_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/hmg\/ddn384","volume":"18","author":"LM DiBella","year":"2009","unstructured":"DiBella LM, Park A, Sun Z (2009) Zebrafish Tsc1 reveals functional interactions between the cilium and the TOR pathway. Hum Mol Genet 18:595\u2013606","journal-title":"Hum Mol Genet"},{"key":"4088_CR38","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1007\/s00018-018-2761-8","volume":"75","author":"T Rosengren","year":"2018","unstructured":"Rosengren T, Larsen LJ, Pedersen LB, Christensen ST, Moller LB (2018) TSC1 and TSC2 regulate cilia length and canonical hedgehog signaling via different mechanisms. Cell Mol Life Sci 75:2663\u20132680","journal-title":"Cell Mol Life Sci"},{"key":"4088_CR39","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.1074\/jbc.C500451200","volume":"281","author":"H Chong-Kopera","year":"2006","unstructured":"Chong-Kopera H, Inoki K, Li Y, Zhu T, Garcia-Gonzalo FR, Rosa JL, Guan KL (2006) TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase. J Biol Chem 281:8313\u20138316","journal-title":"J Biol Chem"},{"key":"4088_CR40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-cancerbio-030518-055533","volume":"3","author":"AM Jaeger","year":"2019","unstructured":"Jaeger AM, Whitesell L (2019) HSP90: enabler of cancer adaptation. Annu Rev Cancer Biol 3:275\u2013297","journal-title":"Annu Rev Cancer Biol"},{"key":"4088_CR41","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.15252\/embj.201796700","volume":"36","author":"MR Woodford","year":"2017","unstructured":"Woodford MR, Sager RA, Marris E, Dunn DM, Blanden AR, Murphy RL, Rensing N, Shapiro O, Panaretou B, Prodromou C, Loh SN, Gutmann DH, Bourboulia D, Bratslavsky G, Wong M, Mollapour M (2017) Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients. EMBO J 36:3650\u20133665","journal-title":"EMBO J"},{"key":"4088_CR42","doi-asserted-by":"publisher","first-page":"5824","DOI":"10.18632\/oncotarget.27217","volume":"10","author":"MR Woodford","year":"2019","unstructured":"Woodford MR, Hughes M, Sager RA, Backe SJ, Baker-Williams AJ, Bratslavsky MS, Jacob JM, Shapiro O, Wong M, Bratslavsky G, Bourboulia D, Mollapour M (2019) Mutation of the co-chaperone Tsc1 in bladder cancer diminishes Hsp90 acetylation and reduces drug sensitivity and selectivity. Oncotarget 10:5824\u20135834","journal-title":"Oncotarget"},{"key":"4088_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev-cancerbio-041816-122338","volume":"1","author":"N Santana-Codina","year":"2017","unstructured":"Santana-Codina N, Mancias JD, Kimmelman AC (2017) The role of autophagy in cancer. Annu Rev Cancer Biol 1:19\u201339","journal-title":"Annu Rev Cancer Biol"},{"key":"4088_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nm.3097","volume":"19","author":"M Papadakis","year":"2013","unstructured":"Papadakis M, Hadley G, Xilouri M, Hoyte LC, Nagel S, McMenamin MM, Tsaknakis G, Watt SM, Drakesmith CW, Chen R, Wood MJ, Zhao Z, Kessler B, Vekrellis K, Buchan AM (2013) Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nat Med 19:351\u2013357","journal-title":"Nat Med"},{"key":"4088_CR45","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/hmg\/ddu101","volume":"23","author":"A Di Nardo","year":"2014","unstructured":"Di Nardo A, Wertz MH, Kwiatkowski E, Tsai PT, Leech JD, Greene-Colozzi E, Goto J, Dilsiz P, Talos DM, Clish CB, Kwiatkowski DJ, Sahin M (2014) Neuronal Tsc1\/2 complex controls autophagy through AMPK-dependent regulation of ULK1. Hum Mol Genet 23:3865\u20133874","journal-title":"Hum Mol Genet"},{"key":"4088_CR46","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4161\/auto.25722","volume":"9","author":"P Castets","year":"2013","unstructured":"Castets P, Ruegg MA (2013) MTORC1 determines autophagy through ULK1 regulation in skeletal muscle. Autophagy 9:1435\u20131437","journal-title":"Autophagy"},{"key":"4088_CR47","doi-asserted-by":"publisher","first-page":"109219","DOI":"10.1016\/j.biopha.2019.109219","volume":"118","author":"R Qi","year":"2019","unstructured":"Qi R, Zhang X, Xie Y, Jiang S, Liu Y, Liu X, Xie W, Jia X, Bade R, Shi R, Li S, Ren C, Gong K, Zhang C, Shao G (2019) 5-Aza-2\u2019-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1\/mTOR pathway. Biomed Pharmacother 118:109219","journal-title":"Biomed Pharmacother"},{"key":"4088_CR48","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/eji.201041336","volume":"41","author":"S Benhamron","year":"2011","unstructured":"Benhamron S, Tirosh B (2011) Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation and loss of marginal zone B cells. Eur J Immunol 41:2390\u20132396","journal-title":"Eur J Immunol"},{"key":"4088_CR49","doi-asserted-by":"publisher","first-page":"e0127527","DOI":"10.1371\/journal.pone.0127527","volume":"10","author":"X Ci","year":"2015","unstructured":"Ci X, Kuraoka M, Wang H, Carico Z, Hopper K, Shin J, Deng X, Qiu Y, Unniraman S, Kelsoe G, Zhong XP (2015) TSC1 promotes B cell maturation but is dispensable for germinal center formation. PLoS ONE 10:e0127527","journal-title":"PLoS ONE"},{"key":"4088_CR50","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1182\/blood-2011-05-353342","volume":"119","author":"J Shin","year":"2012","unstructured":"Shin J, Pan H, Zhong XP (2012) Regulation of mast cell survival and function by tuberous sclerosis complex 1. Blood 119:3306\u20133314","journal-title":"Blood"},{"key":"4088_CR51","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.4049\/jimmunol.1102187","volume":"188","author":"H Pan","year":"2012","unstructured":"Pan H, O\u2019Brien TF, Zhang P, Zhong XP (2012) The role of tuberous sclerosis complex 1 in regulating innate immunity. J Immunol 188:3658\u20133666","journal-title":"J Immunol"},{"key":"4088_CR52","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1038\/ncomms5696","volume":"5","author":"L Zhu","year":"2014","unstructured":"Zhu L, Yang T, Li L, Sun L, Hou Y, Hu X, Zhang L, Tian H, Zhao Q, Peng J, Zhang H, Wang R, Yang Z, Zhang L, Zhao Y (2014) TSC1 controls macrophage polarization to prevent inflammatory disease. Nat Comm 5:4696","journal-title":"Nat Comm"},{"key":"4088_CR53","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1159\/000430306","volume":"36","author":"C Fang","year":"2015","unstructured":"Fang C, Yu J, Luo Y, Chen S, Wang W, Zhao C, Sun Z, Wu W, Guo W, Han Z, Hu X, Liao F, Feng X (2015) Tsc1 is a critical regulator of macrophage survival and function. Cell Physiol Biochem 36:1406\u20131418","journal-title":"Cell Physiol Biochem"},{"key":"4088_CR54","doi-asserted-by":"publisher","first-page":"E4894","DOI":"10.1073\/pnas.1308905110","volume":"110","author":"Y Wang","year":"2013","unstructured":"Wang Y, Huang G, Zeng H, Yang K, Lamb RF, Chi H (2013) Tuberous sclerosis 1 (Tsc1)-dependent metabolic checkpoint controls development of dendritic cells. Proc Natl Acad Sci USA 110:E4894\u2013E4903","journal-title":"Proc Natl Acad Sci USA"},{"key":"4088_CR55","doi-asserted-by":"publisher","first-page":"e2553","DOI":"10.1038\/cddis.2016.487","volume":"8","author":"Y Luo","year":"2017","unstructured":"Luo Y, Li W, Yu G, Yu J, Han L, Xue T, Sun Z, Chen S, Fang C, Zhao C, Niu Q, Yang F, Han Z, Cheng T, Zeng Y, Liao F, Xu G, Feng X (2017) Tsc1 expression by dendritic cells is required to preserve T-cell homeostasis and response. Cell Death Dis 8:e2553","journal-title":"Cell Death Dis"},{"key":"4088_CR56","doi-asserted-by":"publisher","first-page":"699","DOI":"10.4049\/jimmunol.1201443","volume":"191","author":"H Pan","year":"2013","unstructured":"Pan H, O\u2019Brien TF, Wright G, Yang J, Shin J, Wright KL, Zhong XP (2013) Critical role of the tumor suppressor TSC1 for dendritic cell to activate CD4 T cells by promoting MHC class II expression via IRF4 and CIITA. J Immunol 191:699\u2013707","journal-title":"J Immunol"},{"key":"4088_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yexcr.2017.12.028","volume":"363","author":"Y Luo","year":"2018","unstructured":"Luo Y, Liu J, Sun X, Feng T, Fang L, Chen S, Fang C, Feng X, Huang H (2018) Tsc1-dependent transcriptional programming of dendritic cell homeostasis and function. Exp Cell Res 363:73\u201383","journal-title":"Exp Cell Res"},{"key":"4088_CR58","doi-asserted-by":"publisher","first-page":"e3000420","DOI":"10.1371\/journal.pbio.3000420","volume":"17","author":"L Shi","year":"2019","unstructured":"Shi L, Chen X, Zang A, Li T, Hu Y, Ma S, Lu M, Yin H, Wang H, Zhang X, Zhang B, Leng Q, Yang J, Xiao H (2019) TSC1\/mTOR-controlled metabolic-epigenetic cross talk underpins DC control of CD8+ T-cell homeostasis. PLoS Biol 17:e3000420","journal-title":"PLoS Biol"},{"key":"4088_CR59","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.4049\/jimmunol.1003968","volume":"187","author":"Q Wu","year":"2011","unstructured":"Wu Q, Liu Y, Chen C, Ikenoue T, Qiao Y, Li CS, Guan KL, Liu Y, Zheng P (2011) The tuberous sclerosis complex -mTOR pathway maintains the quiescence and survival of naive T-cells. J Immunol 187:1106\u20131112","journal-title":"J Immunol"},{"key":"4088_CR60","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1038\/ni.2068","volume":"12","author":"K Yang","year":"2011","unstructured":"Yang K, Neale G, Green DR, He W, Chi H (2011) Tuberous sclerosis complex 1 (Tsc1) enforces quiescence of naive T-cells to promote immune homeostasis and function. Nat Immunol 12:888\u2013897","journal-title":"Nat Immunol"},{"key":"4088_CR61","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1002\/eji.201141411","volume":"41","author":"TF O'Brien","year":"2011","unstructured":"O\u2019Brien TF, Gorentla BK, Xie D, Srivatsan S, McLeod IX, He YW, Zhong XP (2011) Regulation of T-cell survival and mitochondrial homeostasis by TSC1. Eur J Immunol 41:3361\u20133370","journal-title":"Eur J Immunol"},{"key":"4088_CR62","doi-asserted-by":"publisher","first-page":"e30592","DOI":"10.1371\/journal.pone.0030592","volume":"7","author":"L Zhang","year":"2012","unstructured":"Zhang L, Zhang H, Li L, Xiao Y, Rao E, Miao Z, Chen H, Sun L, Li H, Liu G, Zhao Y (2012) TSC1\/2 signaling complex is essential for peripheral na\u00efve CD8+ T-cell survival and homeostasis in mice. PLoS ONE 7:e30592","journal-title":"PLoS ONE"},{"key":"4088_CR63","doi-asserted-by":"publisher","first-page":"14152","DOI":"10.1073\/pnas.1119744109","volume":"109","author":"DL Xie","year":"2012","unstructured":"Xie DL, Wu J, Lou YL, Zhong XP (2012) Tumor suppressor TSC1 is critical for T-cell anergy. Proc Natl Acad Sci USA 109:14152\u201314157","journal-title":"Proc Natl Acad Sci USA"},{"key":"4088_CR64","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1172\/JCI69751","volume":"123","author":"Y Park","year":"2013","unstructured":"Park Y, Jin HS, Lopez J, Elly C, Kim G, Murai M, Kronenberg M, Liu YC (2013) TSC1 regulates the balance between effector and regulatory T-cells. J Clin Invest 123:5165\u20135178","journal-title":"J Clin Invest"},{"key":"4088_CR65","doi-asserted-by":"publisher","first-page":"E776","DOI":"10.1073\/pnas.1315435111","volume":"111","author":"J Shin","year":"2014","unstructured":"Shin J, Wang S, Deng W, Wu J, Gao J, Zhong XP (2014) Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function. Proc Natl Acad Sci USA 111:E776\u2013E783","journal-title":"Proc Natl Acad Sci USA"},{"key":"4088_CR66","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1172\/JCI69780","volume":"124","author":"J Wu","year":"2014","unstructured":"Wu J, Yang J, Yang K, Wang H, Gorentla B, Shin J, Qiu Y, Que LG, Foster WM, Xia Z, Chi H, Zhong XP (2014) iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions. J Clin Invest 124:1685\u20131698","journal-title":"J Clin Invest"},{"key":"4088_CR67","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.4049\/jimmunol.1302076","volume":"192","author":"J Wu","year":"2014","unstructured":"Wu J, Shin J, Xie D, Wang H, Gao J, Zhong XP (2014) TSC1 promotes iNKT cell anergy and inhibits iNKT cell-mediated anti-tumor immunity. J Immunol 192:2643\u20132650","journal-title":"J Immunol"},{"key":"4088_CR68","doi-asserted-by":"publisher","first-page":"12730","DOI":"10.1038\/ncomms12730","volume":"7","author":"M Yang","year":"2016","unstructured":"Yang M, Chen S, Du J, He J, Wang Y, Li Z, Liu G, Peng W, Zeng X, Li D, Xu P, Guo W, Chang Z, Wang S, Tian Z, Dong Z (2016) NK cell development requires Tsc1-dependent negative regulation of IL-15-triggered mTORC1 activation. Nat Commun 7:12730","journal-title":"Nat Commun"},{"key":"4088_CR69","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1128\/IAI.01816-14","volume":"82","author":"S Krishna","year":"2014","unstructured":"Krishna S, Yang J, Wang H, Qiu Y, Zhong XP (2014) Role of tumor suppressor TSC1 in regulating antigen-specific primary and memory CD8 T cell responses to bacterial infection. Infect Immun 82:3045\u20133057","journal-title":"Infect Immun"},{"key":"4088_CR70","doi-asserted-by":"publisher","first-page":"14858","DOI":"10.1073\/pnas.1404264111","volume":"111","author":"S Shrestha","year":"2014","unstructured":"Shrestha S, Yang K, Wei J, Karmaus PW, Neale G, Chi H (2014) Tsc1 promotes the differentiation of memory CD8+ T cells via orchestrating the transcriptional and metabolic programs. Proc Natl Acad Sci USA 111:14858\u201314863","journal-title":"Proc Natl Acad Sci USA"},{"key":"4088_CR71","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1210\/en.2011-1191","volume":"153","author":"Y Tanaka","year":"2012","unstructured":"Tanaka Y, Park JH, Tanwar PS, Kaneko-Tarui T, Mittal S, Lee HJ, Teixeira JM (2012) Deletion of tuberous sclerosis 1 in somatic cells of the murine reproductive tract causes female infertility. Endocrinology 153:404\u2013416","journal-title":"Endocrinology"},{"key":"4088_CR72","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/molehr\/gat016","volume":"19","author":"T Daikoku","year":"2013","unstructured":"Daikoku T, Yoshie M, Xie H, Sun X, Cha J, Ellenson LH, Dey SK (2013) Conditional deletion of Tsc1 in the female reproductive tract impedes normal oviductal and uterine function by enhancing mTORC1 signaling in mice. Mol Hum Reprod 19:463\u2013472","journal-title":"Mol Hum Reprod"},{"key":"4088_CR73","doi-asserted-by":"publisher","first-page":"e54052","DOI":"10.1371\/journal.pone.0054052","volume":"8","author":"L Huang","year":"2013","unstructured":"Huang L, Wang ZB, Jiang ZZ, Hu MW, Lin F, Zhang QH, Luo YB, Hou Y, Zhao Y, Fan HY, Schatten H, Sun QY (2013) Specific disruption of Tsc1 in ovarian granulosa cells promotes ovulation and causes progressive accumulation of corpora lutea. PLoS ONE 8:e54052","journal-title":"PLoS ONE"},{"key":"4088_CR74","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1083\/jcb.200403069","volume":"166","author":"LS Harrington","year":"2004","unstructured":"Harrington LS, Findlay GM, Gray A, Tolkacheva T, Wigfield S, Rebholz H, Barnett J, Leslie NR, Cheng S, Shepherd PR, Gout I, Downes CP, Lamb RF (2004) The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 166:213\u2013223","journal-title":"J Cell Biol"},{"key":"4088_CR75","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.cub.2004.08.026","volume":"14","author":"OJ Shah","year":"2004","unstructured":"Shah OJ, Wang Z, Hunter T (2004) Inappropriate activation of the TSC\/Rheb\/mTOR\/S6K cassette induces IRS1\/2 depletion, insulin resistance and cell survival deficiencies. Curr Biol 14:1650\u20131656","journal-title":"Curr Biol"},{"key":"4088_CR76","first-page":"633","volume":"22","author":"DF Lee","year":"2008","unstructured":"Lee DF, Kuo HP, Chen CT, Wei Y, Chou CK, Hung JY, Yen CJ, Hung MC (2008) IKK\u03b2 suppression of TSC1 function links the mTOR pathway with insulin resistance. Int J Mol Med 22:633\u2013638","journal-title":"Int J Mol Med"},{"key":"4088_CR77","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2007.05.058","volume":"130","author":"DF Lee","year":"2007","unstructured":"Lee DF, Kuo HP, Chen CT, Hsu JM, Chou CK, Wei Y, Sun HL, Li LY, Ping B, Huang WC, He X, Hung JY, Lai CC, Ding Q, Su JL, Yang JY, Sahin AA, Hortobagyi GN, Tsai FJ, Tsai CH, Hung MC (2007) IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130:440\u2013455","journal-title":"Cell"},{"key":"4088_CR78","doi-asserted-by":"publisher","first-page":"E1013","DOI":"10.1152\/ajpendo.00262.2009","volume":"297","author":"H Mori","year":"2009","unstructured":"Mori H, Inoki K, Opland D, Munzberg H, Villanueva EC, Faouzi M, Ikenoue T, Kwiatkowski DJ, MacDougald OA, Myers MG Jr, Guan KL (2009) Critical roles for the TSC-mTOR pathway in \u03b2-cell function. Am J Physiol Endocrinol Metab 297:E1013\u2013E1022","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4088_CR79","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1530\/JOE-16-0276","volume":"232","author":"L Ding","year":"2017","unstructured":"Ding L, Yin Y, Han L, Li Y, Zhao J, Zhang W (2017) TSC1-mTOR signaling determines the differentiation of islet cells. J Endocrinol 232:59\u201370","journal-title":"J Endocrinol"},{"key":"4088_CR80","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2337\/db14-0427","volume":"64","author":"X Xiang","year":"2015","unstructured":"Xiang X, Lan H, Tang H, Yuan F, Xu Y, Zhao J, Li Y, Zhang W (2015) Tuberous sclerosis complex 1-mechanistic target of rapamycin complex 1 signaling determines brown-to-white adipocyte phenotypic switch. Diabetes 64:519\u2013528","journal-title":"Diabetes"},{"key":"4088_CR81","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.bbalip.2016.02.023","volume":"1861","author":"J Magdalon","year":"2016","unstructured":"Magdalon J, Chimin P, Belchior T, Neves RX, Vieira-Lara MA, Andrade ML, Farias TS, Bolsoni-Lopes A, Paschoal VA, Yamashita AS, Kowaltowski AJ, Festuccia WT (2016) Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces visceral adiposity in mice. Biochim Biophys Acta 1861:430\u2013438","journal-title":"Biochim Biophys Acta"},{"key":"4088_CR82","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng Y, Croce CM (2016) The role of microRNAs in human cancer. Signal Transduct Target Ther 1:15004","journal-title":"Signal Transduct Target Ther"},{"key":"4088_CR83","doi-asserted-by":"publisher","first-page":"5316","DOI":"10.1073\/pnas.1202465109","volume":"109","author":"SS Suh","year":"2012","unstructured":"Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, Kim T, Bakacs A, Alder H, Kaur B, Aqeilan RI, Pichiorri F, Croce CM (2012) MicroRNAs\/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci USA 109:5316\u20135321","journal-title":"Proc Natl Acad Sci USA"},{"key":"4088_CR84","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1111\/jcmm.12380","volume":"18","author":"L Song","year":"2014","unstructured":"Song L, Su M, Wang S, Zou Y, Wang X, Wang Y, Cui H, Zhao P, Hui R, Wang J (2014) MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1. J Cell Mol Med 18:2266\u20132274","journal-title":"J Cell Mol Med"},{"key":"4088_CR85","doi-asserted-by":"publisher","first-page":"14993","DOI":"10.18632\/oncotarget.3802","volume":"6","author":"J Du","year":"2015","unstructured":"Du J, Liu S, He J, Liu X, Qu Y, Yan W, Fan J, Li R, Xi H, Fu W, Zhang C, Yang J, Hou J (2015) MicroRNA-451 regulates stemness of side population cells via PI3K\/Akt\/mTOR signaling pathway in multiple myeloma. Oncotarget 6:14993\u201315007","journal-title":"Oncotarget"},{"key":"4088_CR86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s13402-015-0247-3","volume":"39","author":"I Riquelme","year":"2016","unstructured":"Riquelme I, Tapia O, Leal P, Sandoval A, Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA, Peek RM, Araya JC, Roa JC (2016) MiR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K\/AKT\/mTOR pathway. Cell Oncol (Dordr) 39:23\u201333","journal-title":"Cell Oncol (Dordr)"},{"key":"4088_CR87","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3390\/ijms21030877","volume":"21","author":"G Streleckiene","year":"2020","unstructured":"Streleckiene G, Inciuraite R, Juzenas S, Salteniene V, Steponaitiene R, Gyvyte U, Kiudelis G, Leja M, Ruzgys P, Satkauskas S, Kupcinskiene E, Franke S, Thon C, Link A, Kupcinskas J, Skieceviciene J (2020) Mir-20b and mir-451a are involved in gastric carcinogenesis through the PI3K\/AKT\/mTOR signaling pathway: data from gastric cancer patients, cell lines and Ins-Gas mouse model. Int J Mol Sci 21:877","journal-title":"Int J Mol Sci"},{"key":"4088_CR88","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/cercor\/bhu276","volume":"26","author":"AA Dombkowski","year":"2016","unstructured":"Dombkowski AA, Batista CE, Cukovic D, Carruthers NJ, Ranganathan R, Shukla U, Stemmer PM, Chugani HT, Chugani DC (2016) Cortical tubers: windows into dysregulation of epilepsy risk and synaptic signaling genes by microRNAs. Cereb Cortex 26:1059\u20131071","journal-title":"Cereb Cortex"},{"key":"4088_CR89","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fnmol.2017.00160","volume":"10","author":"CY Li","year":"2017","unstructured":"Li CY, Chen YP, Chen XP, Wei QQ, Cao B, Shang HF (2017) Downregulation of microRNA-193b-3p promotes autophagy and cell survival by targeting TSC1\/mTOR signaling in NSC-34 cells. Front Mol Neurosci 10:160","journal-title":"Front Mol Neurosci"},{"key":"4088_CR90","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1038\/cdd.2017.129","volume":"24","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhang X, Tang W, Lin Z, Xu L, Dong R, Li Y, Li J, Zhang Z, Li X, Zhao L, Wei JJ, Shao C, Kong B, Liu Z (2017) MiR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-kappaB in high-grade serous ovarian carcinoma. Cell Death Differ 24:2089\u20132100","journal-title":"Cell Death Differ"},{"key":"4088_CR91","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10753-018-0887-3","volume":"42","author":"N Rezaei","year":"2019","unstructured":"Rezaei N, Talebi F, Ghorbani S, Rezaei A, Esmaeili A, Noorbakhsh F, Hakemi MG (2019) MicroRNA-92a drives Th1 responses in the experimental autoimmune encephalomyelitis. Inflammation 42:235\u2013245","journal-title":"Inflammation"},{"key":"4088_CR92","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1159\/000494821","volume":"50","author":"N Wang","year":"2018","unstructured":"Wang N, Liang X, Yu W, Zhou S, Fang M (2018) Differential expression of microRNA-19b promotes proliferation of cancer stem cells by regulating the TSC1\/mTOR signaling pathway in multiple myeloma. Cell Physiol Biochem 50:1804\u20131814","journal-title":"Cell Physiol Biochem"},{"key":"4088_CR93","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.18632\/oncotarget.23326","volume":"9","author":"G Liu","year":"2018","unstructured":"Liu G, Chen FL, Ji F, Fei HD, Xie Y, Wang SG (2018) MicroRNA-19a protects osteoblasts from dexamethasone via targeting TSC1. Oncotarget 9:2017\u20132027","journal-title":"Oncotarget"},{"key":"4088_CR94","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s11626-018-0292-0","volume":"54","author":"X Yuan","year":"2018","unstructured":"Yuan X, Deng X, Zhou X, Zhang A, Xing Y, Zhang Z, Zhang H, Li J (2018) MiR-126-3p promotes the cell proliferation and inhibits the cell apoptosis by targeting TSC1 in the porcine granulosa cells. Vitro Cell Dev Biol Anim 54:715\u2013724","journal-title":"Vitro Cell Dev Biol Anim"},{"key":"4088_CR95","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.1096\/fj.201901562RR","volume":"34","author":"Y Shi","year":"2020","unstructured":"Shi Y, Li F, Wang S, Wang C, Xie Y, Zhou J, Li X, Wang B (2020) MiR-196b-5p controls adipocyte differentiation and lipogenesis through regulating mTORC1 and TGF-\u03b2 signaling. FASEB J 34:9207\u20139222","journal-title":"FASEB J"},{"key":"4088_CR96","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1080\/15384101.2019.1593648","volume":"18","author":"T Li","year":"2019","unstructured":"Li T, Liu X, Gong X, Qiukai E, Zhang X, Zhang X (2019) MicroRNA 92b\u20133p regulates primordial follicle assembly by targeting TSC1 in neonatal mouse ovaries. Cell Cycle 18:824\u2013833","journal-title":"Cell Cycle"},{"key":"4088_CR97","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/s41418-018-0243-z","volume":"26","author":"J Lee","year":"2019","unstructured":"Lee J, Heo J, Kang H (2019) MiR-92b-3p-TSC1 axis is critical for mTOR signaling-mediated vascular smooth muscle cell proliferation induced by hypoxia. Cell Death Differ 26:1782\u20131795","journal-title":"Cell Death Differ"},{"key":"4088_CR98","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/cas.14325","volume":"111","author":"C Wang","year":"2020","unstructured":"Wang C, Uemura M, Tomiyama E, Matsushita M, Koh Y, Nakano K, Hayashi Y, Ishizuya Y, Jingushi K, Kato T, Hatano K, Kawashima A, Ujike T, Nagahara A, Fujita K, Imamura R, Tsujikawa K, Nonomura N (2020) MicroRNA-92b-3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma. Cancer Sci 111:1146\u20131155","journal-title":"Cancer Sci"},{"key":"4088_CR99","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/ijc.31857","volume":"144","author":"A Sanchez-Mejias","year":"2019","unstructured":"Sanchez-Mejias A, Kwon J, Chew XH, Siemens A, Sohn HS, Jing G, Zhang B, Yang H, Tay Y (2019) A novel SOCS5\/miR-18\/miR-25 axis promotes tumorigenesis in liver cancer. Int J Cancer 144:311\u2013321","journal-title":"Int J Cancer"},{"key":"4088_CR100","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.omtn.2020.05.027","volume":"21","author":"J Wang","year":"2020","unstructured":"Wang J, Li X, Zhong M, Wang Y, Zou L, Wang M, Gong X, Wang X, Zhou C, Ma X, Liu M (2020) MiR-301a suppression within fibroblasts limits the progression of fibrosis through the TSC1\/mTOR pathway. Mol Ther Nucleic Acids 21:217\u2013228","journal-title":"Mol Ther Nucleic Acids"},{"key":"4088_CR101","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12935-020-01234-7","volume":"20","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wang H, Ruan J, Zheng W, Yang Z, Pan W (2020) Long non-coding RNA OIP5-AS1 suppresses multiple myeloma progression by sponging miR-27a-3p to activate TSC1 expression. Cancer Cell Int 20:155","journal-title":"Cancer Cell Int"},{"key":"4088_CR102","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1073\/pnas.151033798","volume":"98","author":"T Kobayashi","year":"2001","unstructured":"Kobayashi T, Minowa O, Sugitani Y, Takai S, Mitani H, Kobayashi E, Noda T, Hino O (2001) A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc Natl Acad Sci USA 98:8762\u20138767","journal-title":"Proc Natl Acad Sci USA"},{"key":"4088_CR103","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/hmg\/11.5.525","volume":"11","author":"DJ Kwiatkowski","year":"2002","unstructured":"Kwiatkowski DJ, Zhang H, Bandura JL, Heiberger KM, Glogauer M, El-Hashemite N, Onda H (2002) A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet 11:525\u2013534","journal-title":"Hum Mol Genet"},{"key":"4088_CR104","doi-asserted-by":"publisher","first-page":"8937","DOI":"10.1158\/0008-5472.CAN-10-1646","volume":"70","author":"RD Kladney","year":"2010","unstructured":"Kladney RD, Cardiff RD, Kwiatkowski DJ, Chiang GG, Weber JD, Arbeit JM, Lu ZH (2010) Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice. Cancer Res 70:8937\u20138947","journal-title":"Cancer Res"},{"key":"4088_CR105","doi-asserted-by":"publisher","first-page":"ra24","DOI":"10.1126\/scisignal.2002739","volume":"5","author":"S Menon","year":"2012","unstructured":"Menon S, Yecies JL, Zhang HH, Howell JJ, Nicholatos J, Harputlugil E, Bronson RT, Kwiatkowski DJ, Manning BD (2012) Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice. Sci Signal 5:ra24","journal-title":"Sci Signal"},{"key":"4088_CR106","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.neo.2014.08.010","volume":"16","author":"L Ding","year":"2014","unstructured":"Ding L, Han L, Li Y, Zhao J, He P, Zhang W (2014) Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma. Neoplasia 16:909\u2013917","journal-title":"Neoplasia"},{"key":"4088_CR107","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.ccell.2015.10.004","volume":"28","author":"S Sun","year":"2015","unstructured":"Sun S, Chen S, Liu F, Wu H, McHugh J, Bergin IL, Gupta A, Adams D, Guan JL (2015) Constitutive activation of mTORC1 in endothelial cells leads to the development and progression of lymphangiosarcoma through VEGF autocrine signaling. Cancer Cell 28:758\u2013772","journal-title":"Cancer Cell"},{"key":"4088_CR108","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41598-017-00970-7","volume":"7","author":"HM Zhang","year":"2017","unstructured":"Zhang HM, Diaz V, Walsh ME, Zhang Y (2017) Moderate lifelong overexpression of tuberous sclerosis complex 1 (TSC1) improves health and survival in mice. Sci Rep 7:834","journal-title":"Sci Rep"},{"key":"4088_CR109","doi-asserted-by":"publisher","first-page":"29973","DOI":"10.1074\/jbc.M111.270785","volume":"286","author":"M Ognibene","year":"2011","unstructured":"Ognibene M, Vanni C, Segalerba D, Mancini P, Merello E, Torrisi MR, Bosco MC, Varesio L, Eva A (2011) The tumor suppressor hamartin enhances Dbl protein transforming activity through interaction with ezrin. J Biol Chem 286:29973\u201329983","journal-title":"J Biol Chem"},{"key":"4088_CR110","doi-asserted-by":"publisher","first-page":"e41931","DOI":"10.1371\/journal.pone.0041931","volume":"7","author":"CJ Yen","year":"2012","unstructured":"Yen CJ, Lin YJ, Yen CS, Tsai HW, Tsai TF, Chang KY, Huang WC, Lin PW, Chiang CW, Chang TT (2012) Hepatitis B virus X protein upregulates mTOR signaling through IKK\u03b2 to increase cell proliferation and VEGF production in hepatocellular carcinoma. PLoS ONE 7:e41931","journal-title":"PLoS ONE"},{"key":"4088_CR111","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3906\/biy-1801-57","volume":"42","author":"SI Goktuna","year":"2018","unstructured":"Goktuna SI (2018) IKBKE inhibits TSC1 to activate the mTOR\/S6K pathway for oncogenic transformation. Turk J Biol 42:268\u2013278","journal-title":"Turk J Biol"},{"key":"4088_CR112","doi-asserted-by":"publisher","first-page":"15960","DOI":"10.1074\/jbc.M110.121871","volume":"285","author":"S Khatri","year":"2010","unstructured":"Khatri S, Yepiskoposyan H, Gallo CA, Tandon P, Plas DR (2010) FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1. J Biol Chem 285:15960\u201315965","journal-title":"J Biol Chem"},{"key":"4088_CR113","doi-asserted-by":"publisher","first-page":"12361","DOI":"10.1074\/jbc.M213069200","volume":"278","author":"DR Plas","year":"2003","unstructured":"Plas DR, Thompson CB (2003) Akt activation promotes degradation of tuberin and FOXO3a via the proteosome. J Biol Chem 278:12361\u201312366","journal-title":"J Biol Chem"},{"key":"4088_CR114","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/0008-5472.CAN-18-2738","volume":"79","author":"M Song","year":"2019","unstructured":"Song M, Bode AM, Dong Z, Lee MH (2019) AKT as a therapeutic target for cancer. Cancer Res 79:1019\u20131031","journal-title":"Cancer Res"},{"key":"4088_CR115","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1158\/0008-5472.CAN-18-2049","volume":"79","author":"L Wu","year":"2019","unstructured":"Wu L, Yi B, Wei S, Rao D, He Y, Naik G, Bae S, Liu XM, Yang WH, Sonpavde G, Liu R, Wang L (2019) Loss of FOXP3 and TSC1 accelerates prostate cancer progression through synergistic transcriptional and posttranslational regulation of c-MYC. Cancer Res 79:1413\u20131425","journal-title":"Cancer Res"},{"key":"4088_CR116","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI133264","volume":"130","author":"Y Xie","year":"2020","unstructured":"Xie Y, Zhao Y, Shi L, Li W, Chen K, Li M, Chen X, Zhang H, Li T, Matsuzawa-Ishimoto Y, Yao X, Shao D, Ke Z, Li J, Chen Y, Zhang X, Cui J, Cui S, Leng Q, Cadwell K, Li X, Wei H, Zhang H, Li H, Xiao H (2020) Gut epithelial TSC1\/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer. J Clin Invest 130:2111\u20132128","journal-title":"J Clin Invest"},{"key":"4088_CR117","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1128\/MCB.01570-12","volume":"33","author":"TA Tran","year":"2013","unstructured":"Tran TA, Kinch L, Pe\u00f1a-Llopis S, Kockel L, Grishin N, Jiang H, Brugarolas J (2013) Platelet-derived growth factor\/vascular endothelial growth factor receptor inactivation by sunitinib results in Tsc1\/Tsc2-dependent inhibition of TORC1. Mol Cell Biol 33:3762\u20133779","journal-title":"Mol Cell Biol"},{"key":"4088_CR118","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s10549-010-1062-1","volume":"125","author":"MS Mehta","year":"2011","unstructured":"Mehta MS, Vazquez A, Kulkarni DA, Kerrigan JE, Atwal G, Metsugi S, Toppmeyer DL, Levine AJ, Hirshfield KM (2011) Polymorphic variants in TSC1 and TSC2 and their association with breast cancer phenotypes. Breast Cancer Res Treat 125:861\u2013868","journal-title":"Breast Cancer Res Treat"},{"key":"4088_CR119","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1074\/jbc.M113.526335","volume":"289","author":"Y Chen","year":"2014","unstructured":"Chen Y, Wei H, Liu F, Guan JL (2014) Hyperactivation of mammalian target of rapamycin complex 1 (mTORC1) promotes breast cancer progression through enhancing glucose starvation-induced autophagy and Akt signaling. J Biol Chem 289:1164\u20131173","journal-title":"J Biol Chem"},{"key":"4088_CR120","doi-asserted-by":"publisher","first-page":"27097","DOI":"10.18632\/oncotarget.4553","volume":"6","author":"HP Lin","year":"2015","unstructured":"Lin HP, Lin CY, Huo C, Jan YJ, Tseng JC, Jiang SS, Kuo YY, Chen SC, Wang CT, Chan TM, Liou JY, Wang J, Chang WS, Chang CH, Kung HJ, Chuu CP (2015) AKT3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf, and TSC1\/TSC2. Oncotarget 6:27097\u201327112","journal-title":"Oncotarget"},{"key":"4088_CR121","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1471-2407-8-163","volume":"8","author":"S Chakraborty","year":"2008","unstructured":"Chakraborty S, Mohiyuddin SMA, Gopinath KS, Kumar A (2008) Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma. BMC Cancer 8:163","journal-title":"BMC Cancer"},{"key":"4088_CR122","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1158\/1078-0432.CCR-15-2631","volume":"22","author":"DJ Kwiatkowski","year":"2016","unstructured":"Kwiatkowski DJ, Choueiri TK, Fay AP, Rini B, Thorner AR, de Velasco G, Tyburczy ME, Hamieh L, Albiges L, Agarwal N, Ho TH, Song J, Pignon JC, Barrios PM, Michaelson MD, Allen EV, Krajewski KM, Porta C, Pal S, Bellmunt J, McDermott DF, Heng DYC, Gray KP, Signoretti S (2016) Mutations in TSC1, TSC2, and MTOR are associated with response to rapalogs in patients with metastatic renal cell carcinoma. Clin Cancer Res 22:2445\u20132452","journal-title":"Clin Cancer Res"},{"key":"4088_CR123","first-page":"7652","volume":"63","author":"MA Knowles","year":"2003","unstructured":"Knowles MA, Habuchi T, Kennedy W, Cuthbert-Heavens D (2003) Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder. Cancer Res 63:7652\u20137656","journal-title":"Cancer Res"},{"key":"4088_CR124","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/path.4176","volume":"230","author":"Y Guo","year":"2013","unstructured":"Guo Y, Chekaluk Y, Zhang J, Du J, Gray NS, Wu CL, Kwiatkowski DJ (2013) TSC1 involvement in bladder cancer: diverse effects and therapeutic implications. J Pathol 230:17\u201327","journal-title":"J Pathol"},{"key":"4088_CR125","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1136\/gutjnl-2016-312734","volume":"66","author":"DWH Ho","year":"2017","unstructured":"Ho DWH, Chan LK, Chiu YT, Xu IMJ, Poon RTP, Cheung TT, Tang CN, Tang VWL, Lo ILO, Lam PWY, Yau DTW, Li MX, Wong CM, Ng IOL (2017) TSC1\/2 mutations define a molecular subset of HCC with aggressive behavior and treatment implication. Gut 66:1496\u20131506","journal-title":"Gut"},{"key":"4088_CR126","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/onc.2009.452","volume":"29","author":"MC Liang","year":"2010","unstructured":"Liang MC, Ma J, Chen L, Kozlowski P, Qin W, Li D, Shimamura T, Thomas RK, Hayes ND, Meyerson M, Kwiatkowski DJ, Wong KK (2010) TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity. Oncogene 29:1588\u20131597","journal-title":"Oncogene"},{"key":"4088_CR127","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ejca.2005.03.023","volume":"41","author":"WG Jiang","year":"2005","unstructured":"Jiang WG, Sampson J, Martin TA, Lee-Jones L, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE (2005) Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes. Eur J Cancer 41:1628\u20131636","journal-title":"Eur J Cancer"},{"key":"4088_CR128","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/jso.23585","volume":"109","author":"SJ Byeon","year":"2014","unstructured":"Byeon SJ, Han N, Choi J, Kim MA, Kim WH (2014) Prognostic implication of TSC1 and mTOR expression in gastric carcinoma. J Surg Oncol 109:812\u2013817","journal-title":"J Surg Oncol"},{"key":"4088_CR129","doi-asserted-by":"publisher","first-page":"S634","DOI":"10.1245\/s10434-014-3729-z","volume":"21","author":"SJ Lee","year":"2014","unstructured":"Lee SJ, Kang BW, Chae YS, Kim HJ, Park SY, Park JS, Choi GS, Jeon HS, Lee WK, Kim JG (2014) Genetic variations in STK11, PRKAA1, and TSC1 associated with prognosis for patients with colorectal cancer. Ann Surg Oncol 21:S634\u2013S639","journal-title":"Ann Surg Oncol"},{"key":"4088_CR130","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00432-017-2550-z","volume":"144","author":"M Ma","year":"2018","unstructured":"Ma M, Dai J, Xu T, Yu S, Yu H, Tang H, Yan J, Wu X, Yu J, Chi Z, Si L, Cui C, Sheng X, Kong Y, Guo J (2018) Analysis of TSC1 mutation spectrum in mucosal melanoma. J Cancer Res Clin Oncol 144:257\u2013267","journal-title":"J Cancer Res Clin Oncol"},{"key":"4088_CR131","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.4161\/cc.8.8.8139","volume":"8","author":"C Chen","year":"2009","unstructured":"Chen C, Liu Y, Liu Y, Zheng P (2009) The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells. Cell Cycle 8:1158\u20131160","journal-title":"Cell Cycle"},{"key":"4088_CR132","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.3390\/cells9092072","volume":"9","author":"MV Guijarro","year":"2020","unstructured":"Guijarro MV, Danielson LS, Ca\u00f1amero M, Nawab A, Abrahan C, Hernando E, Palmer GD (2020) Tsc1 regulates the proliferation capacity of bone-marrow derived mesenchymal stem cells. Cells 9:2072","journal-title":"Cells"},{"key":"4088_CR133","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1158\/0008-5472.CAN-06-2875","volume":"67","author":"CL Pelletier","year":"2007","unstructured":"Pelletier CL, Maggi LB Jr, Brady SN, Scheidenhelm DK, Gutmann DH, Weber JD (2007) TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation. Cancer Res 67:1609\u20131617","journal-title":"Cancer Res"},{"key":"4088_CR134","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/cdd.2010.82","volume":"18","author":"YJ Kang","year":"2011","unstructured":"Kang YJ, Lu MK, Guan KL (2011) The TSC1 and TSC2 tumor suppressors are required for proper ER stress response and protect cells from ER stress-induced apoptosis. Cell Death Differ 18:133\u2013144","journal-title":"Cell Death Differ"},{"key":"4088_CR135","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.molcel.2007.12.023","volume":"29","author":"U Ozcan","year":"2008","unstructured":"Ozcan U, Ozcan L, Yilmaz E, Duvel K, Sahin M, Manning BD, Hotamisligil GS (2008) Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell 29:541\u2013551","journal-title":"Mol Cell"},{"key":"4088_CR136","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/hmg\/ddi039","volume":"14","author":"L Meikle","year":"2005","unstructured":"Meikle L, McMullen JR, Sherwood MC, Lader AS, Walker V, Chan JA, Kwiatkowski DJ (2005) A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes. Hum Mol Genet 14:429\u2013435","journal-title":"Hum Mol Genet"},{"key":"4088_CR137","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jgg.2013.11.005","volume":"41","author":"Y Chen","year":"2014","unstructured":"Chen Y, Wang F, Li C, Wang L, Zhang H, Yan H (2014) Acquired cardiomyopathy caused by cardiac Tsc1 deficiency. J Genet Genom 41:73\u201377","journal-title":"J Genet Genom"},{"key":"4088_CR138","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.carpath.2014.10.005","volume":"24","author":"US Kayyali","year":"2015","unstructured":"Kayyali US, Larsen CG, Bashiruddin S, Lewandowski SL, Trivedi CM, Warburton RR, Parkhitko AA, Morrison TA, Henske EP, Chekaluk Y, Kwiatkowski DJ, Finlay GA (2015) Targeted deletion of Tsc1 causes fatal cardiomyocyte hyperplasia independently of afterload. Cardiovasc Pathol 24:80\u201393","journal-title":"Cardiovasc Pathol"},{"key":"4088_CR139","doi-asserted-by":"publisher","first-page":"19587","DOI":"10.1038\/srep19587","volume":"6","author":"Z Qin","year":"2016","unstructured":"Qin Z, Zheng H, Zhou L, Ou Y, Huang B, Yan B, Qin Z, Yang C, Su Y, Bai X, Guo J, Lin J (2016) Tsc1 deficiency impairs mammary development in mice by suppression of AKT, nuclear ER\u03b1 and cell-cycle-driving proteins. Sci Rep 6:19587","journal-title":"Sci Rep"},{"key":"4088_CR140","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.bbrc.2018.02.201","volume":"498","author":"H Li","year":"2018","unstructured":"Li H, Ren Y, Mao K, Hua F, Yang Y, Wei N, Yue C, Li D, Zhang H (2018) FTO is involved in Alzheimer\u2019s disease by targeting TSC1-mTOR-Tau signaling. Biochem Biophys Res Commun 498:234\u2013239","journal-title":"Biochem Biophys Res Commun"},{"key":"4088_CR141","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/s41418-017-0049-4","volume":"25","author":"S Xu","year":"2018","unstructured":"Xu S, Zhang Y, Wang J, Li K, Tan K, Liang K, Shen J, Cai D, Jin D, Li M, Xiao G, Xu J, Jiang Y, Bai X (2018) TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1\/Cdc42. Cell Death Differ 25:1549\u20131566","journal-title":"Cell Death Differ"},{"key":"4088_CR142","doi-asserted-by":"publisher","first-page":"180262","DOI":"10.1098\/rsob.180262","volume":"9","author":"W Liu","year":"2019","unstructured":"Liu W, Wang Z, Yang J, Wang Y, Li K, Huang B, Yan B, Wang T, Li M, Zou Z, Yang J, Xiao G, Cui ZK, Liu A, Bai X (2019) Osteocyte TSC1 promotes sclerostin secretion to restrain osteogenesis in mice. Open Biol 9:180262","journal-title":"Open Biol"},{"key":"4088_CR143","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1002\/jbmr.3530","volume":"33","author":"HK Choi","year":"2018","unstructured":"Choi HK, Yuan H, Fang F, Wei X, Liu L, Li Q, Guan JL, Liu F (2018) Tsc1 regulates the balance between osteoblast and adipocyte differentiation through Autophagy\/Notch1\/\u03b2-Catenin cascade. J Bone Miner Res 33:2021\u20132034","journal-title":"J Bone Miner Res"},{"key":"4088_CR144","first-page":"4572687","volume":"2020","author":"C Yang","year":"2020","unstructured":"Yang C, Liao J, Lai P, Huang H, Fan S, Chen Y, Bai X (2020) Mesenchymal stem cell-specific and preosteoblast-specific ablation of TSC1 in mice lead to severe and slight spinal dysplasia, respectively. Biomed Res Int 2020:4572687","journal-title":"Biomed Res Int"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04088-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04088-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04088-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T07:12:22Z","timestamp":1674976342000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04088-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":144,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["4088"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04088-3","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"11 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Both authors declare that there are no conflict of interest. No financial affiliation or involvement with any commercial organization with direct financial interest in the subject or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}